Seminar Series
An annual Seminar Series is co-sponsored by the Institute for Hepatitis and Virus Research (IHVR), the Hepatitis B Foundation, and the Drexel Institute to promote scientific exchange at the national and international level.
January 8 - 11:00 AM - Chuck Reynolds, PhD (Johnson & Johnson)
"Application of Computer Modeling in Drug Discovery"
January 30 - 11:00 AM - Yvonne Paterson, PhD (Dept. of Microbiology, University of Pennsylvania School of Medicine)
"A Multi-pronged Approach to Tumor Immunotherapy Using Listeria Monocytogenes as an Antigen Delivery Vehicle"
February 13 - 11:00 AM - Sandhya Kortagers, PhD (Microbiology and Immunology, Drexel University College of Medicine)
"Hybrid Structure Based Method and its Application to Design New Lead Compounds"
March 3 - 11:00 AM - Brian Haab, PhD (Laboratory of Cancer Immunodiagnostics, Van Andel Institute)
"The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Glycan Sandwich Arrays"
March 11 - 11:00 AM - Wai Law, PhD (PortaScience, Inc.)
"Point-of-Care Testing for WBCs"
March 19 - 4:00 PM - Dr. Stephen Locarnini (Victorian Infectious Diseases Reference Laboratory / WHO Collaborating Centre for Virus Reference & Research)
The Virology of Hepatitis B Immunomodulation and Therapy"
Hepatitis B Foundation's 2009 Bruce Witte Lecturer
March 25 - 11:00 AM - Dr. Wolfram Gerlich (Institute for Medical Virology, Geissen, Germany)
"Escape Mutants in Occult and Reactivated Hepatitis B Virus Infection"
April 8 - 11:00 AM - Dr. Harvey Friedman (Infectious Disease Division, University of Pennsylvania School of Medicine)
"TBA"
April 16 - 11:00 AM - Paul Ahlquist, PhD (Institute for Molecular Virology, University of Wisconsin)
"TBA"
April 27 - 11:00 AM - Raymond Dwek, FRS (Oxford Glycobiology Institute, University of Oxford)
"Glycobiology - Leading to Novel Therapies for Hepatitis and HIV"
May 14 - 11:00 AM - Arul Chinnaiyan, MD, PhD (University of Michigan Center for Translational Pathology)
"TBA"
May 20 - 11:00 AM - Dr. David Kaplan (Gastroenterology Division, University of Pennsylvania School of Medicine)
"Dysfunctional Tumor Antigen-Specific T-Cell Responses in Hepatocellular Carcinoma"
June 17 - 11:00 AM - Terry Butters, PhD (Glycobiology Institute, University of Oxford)
"TBA"
*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
January 4 - 11:00 AM - John Blaho, PhD (Virology Research Division, Medical Diagnostic Laboratories)
"Apoptosis During HSV Infection"
January 11 - 11:00 AM - Shohreh Amini, PhD (Temple University Centre for Neurovirology and Cancer Biology)
"p27SJ Downregulates HIV-1 gene Expression"
January 18 - 11:00 AM - Stephan Menne, PhD (Cornell University College of Veterinary Medicine)
"The Woodchuck Model for Therapy of Chronic Hepatitis B Virus Infection Including Hepatocellular Carcinoma"
*January 22 - 4:00 PM - Joseph J. Villafranca, PhD (Senior Vice President of Operations, Tunnell Consulting)
"Drug Discovery to Commercialization: A Challenging Road"
January 25 - 11:00 AM - Anthony T. Yeung, PhD (Fox Chase Cancer Center)
"Proteomic Analysis of Pancreatic Cyst Fluids"
February 8 - 11:00 AM - Michael Pierce, PhD (University of Georgia Cancer Center)
"Exploiting Glycomics to Identify Cancer Markers"
February 14 - 11:00 AM - Dan Loeb, PhD (University of Wisconsin, Madison)
"HBV Reverse Transcription: Dynamic RNA/DNA Template Conformations Direct Genome Replication"
*February 29 - 1:30 PM - Thomas L. Richard, PhD (Pennsylvania State University)
"Science and Entrepreneurism in Alternative Energy Technologies"
March 7 - 11:00 AM - Terry Butters, PhD (University of Oxford)
"Free Oligosacharides as Evidence of Protein Degradation"
April 11 - 4:00 PM - Anna Lok, MD, MRCP (University of Michigan)
"Antiviral Drug-Resistant Hepatitis B: Can we Prevent this Monster from Growing?"
Presented through the Hepatitis B Foundation/Commonwealth Institute Distinguished Lectureship Series
April 22 - 4:00 PM - Rafi Ahmed, PhD (Emory University Vaccine Center)
"Immunological Strategies for Treating Chronic Viral Infections"
Hepatitis B Foundation’s 2008 Bruce Witte Lecturer
May 9 - 11:00 AM - Dr. Sina Bavari (Immunology, Target Identification & Translational Research, USAMRIID
“TBA"
May 16 - 2:00 PM -Pauline Rudd, PhD (National Institute for Bioprocessing Research and Training, University College of Dublin)
"Glycobiology: The Importance of Glycosylation from the Bench to the Clinic"
May 23 - 11:00 AM - Herman Staats, MD (Duke Human Vaccine Institute, Duke University)
"Adjuvants and Formulations for Nasally-Administered Botulinum Vaccines: Preclinical Studies in Mice and Rabbits"
June 10 - 11:00 AM - Alfonso Tobia, PhD (Hy BioPharma)
"Hypericin: A Novel Anti-Cancer Drug, its Discovery and Clinical Development to Phase III Trials "
July 25 - 11:00 AM - Pei-Yong Shi, PhD (Laboratory of Virology, Division of Infectious Diseases, Wadsworth Center)
"Flaviviris Methyltransferase: A Novel Target for Antiviral and Vaccine Development "
July 30 - 4:00 PM - Brian Carr, MD, PhD, FRCP (Liver Tumor Program, Kimmel Cancer Center - Thomas Jefferson University Medical College)
"New Treatments for HCC: How the Biology Drives Therapy "
August 6 - 11:00 AM - Patrick Romano, PhD
"Defining Cellular Responses and Development of RNAi Based Drugs Targeting Influenza "
September 11 - 2:00 PM - Allen Reitz, PhD
"Fragment Based Drug Discovery"
October 10 - 8:00 AM - 1:00 PM Annual Biotech Conference (Sponsored by Regional Biotech Council)
October 17 - 11:00 AM - Robin Morgan, PhD (College of Agriculture and Natural Resources, University of Delaware)
"Marek's Disease Virus MicrosRNAs: Insights Into Herpesvirus Oncology"
October 29 - 11:00 AM - Joel D. Pardee, PhD (Weill Cornell Medical College, Cornell University)
"M-34 Protein: A Diagnostic Marker for Early Stage Detection of Colon and Breast Carcinoma"
November 7 - 11:00 AM - Fred Krebs, PhD (Drexel University College of Medicine)
"Discovery and Development of Biguanide-Based, Dual Co-Receptor Inhibitors Effective Against HIV-1"
November 12 - 11:00 AM - Brian McMahon, MD (Liver Disease and Hepatitis Program, Alaska Native Medical Center)
"How Long Does Protection from Hepatitis B and A Vaccines Last?"
December 12 - 11:00 AM - Jane Clifford, MD (Dept. of Biochemistry, Drexel University College of Medicine)
"TBA"
December 16 - 4:00 PM - Dr. Herb Taylor* (Vice President, Federal Reserve Bank of Philadelphia)
"Understanding Current Financial Turmoil and its Impact on Biotech Entrepreneurs"
"TBA"
*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
 |
 |